Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Changchun Cao
Cyclophosphamide Versus Mycophenolate Mofetil for Initial Treatment of Lupus Nephritis
Kidney International
Nephrology
Long Non-Coding RNA SNHG12 Functions as a Competing Endogenous RNA to Regulate MDM4 Expression by Sponging miR-129-5p in Clear Cell Renal Cell Carcinoma
Frontiers in Oncology
Cancer Research
Oncology
Related publications
Outcomes Following Mycophenolate Mofetil Versus Cyclophosphamide Induction Treatment for Proliferative Juvenile-Onset Lupus Nephritis
Lupus
Rheumatology
Comparative Effectiveness of Mycophenolate Mofetil for the Treatment of Childhood-Onset Proliferative Lupus Nephritis
Arthritis Care and Research
Rheumatology
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis With Poor Kidney Function: A Subgroup Analysis of the Aspreva Lupus Management Study
American Journal of Kidney Diseases
Nephrology
Mycophenolate Mofetil for Induction Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
81 Outcomes of Multi-Target Therapy Using Mycophenolate Mofetil and Tacrolimus for Refractory Lupus Nephritis
Efficacy of High-Dose Mycophenolate Mofetil in Multitarget Therapy for Lupus Nephritis: Two Consecutive Case Reports
Cureus
Randomised Trial of Mycophenolate Mofetil Versus Azathioprine for Treatment of Chronic Active Crohnʼs Disease
European Journal of Gastroenterology and Hepatology
Hepatology
Gastroenterology
Leflunomide Versus Cyclophosphamide in the Induction Treatment of Proliferative Lupus Nephritis in Chinese Patients: A Randomized Trial
Clinical Rheumatology
Medicine
Rheumatology
Mycophenolate Mofetil Reduces STAT3 Phosphorylation in Systemic Lupus Erythematosus Patients
JCI insight
Medicine
